1,578
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Phyto-progestins for the treatment of abnormal uterine bleeding without organic cause in women at high risk for breast cancer and breast cancer survivors: a prospective, pilot study

, , &
Article: 2239936 | Received 15 Mar 2023, Accepted 17 Jul 2023, Published online: 26 Jul 2023

References

  • Traborelli S. Physiology, production and action of progesterone. Acta Obstet Gynecol Scand. 2015;94(Suppl 161):1–5.
  • Sundström-Poromaa I, Comasco E, Sumner R, et al. Progesterone – friend or foe? Front Neuroendocrinol. 2020;59:100856. doi: 10.1016/j.yfrne.2020.100856.
  • Davis KS. The story of the pill. Am Herit. 1978;29(5):80–91.
  • Komesaroff PA, Black CV, Cable V, et al. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric. 2001;4(2):144–150. doi: 10.1080/cmt.4.2.144.150.
  • Liu K, Zhao W, Gao X, et al. Diosgenin ameliorates palmitate-induced endothelial dysfunction. Atherosclerosis. 2012;223(2):350–358. doi: 10.1016/j.atherosclerosis.2012.06.012.
  • Esfandiarei M, Lam JTN, Yazdi SA, et al. Diosgenin modulates vascular smooth muscle cell function by regulating cell viability, migration, and calcium homeostasis. J Pharmacol Exp Ther. 2011;336(3):925–939. doi: 10.1124/jpet.110.172684.
  • Chen Y, Tang YM, Yu SL, et al. Advances in the pharmacological activities and mechanisms of diosgenin. Chin J Nat Med. 2015;13(8):578–587. doi: 10.1016/S1875-5364(15)30053-4.
  • Sethi G, Shanmugam MK, Warrier S, et al. Pro-apoptotic and anti-cancer properties of diosgenin: a comprehensive and critical review. Nutrients. 2018;10(5):645. doi: 10.3390/nu10050645.
  • Gorkow C, Wuttke W, Marz RW. Effectiveness of Vitex agnus castus preparations. Wien Med Wochenschr. 2002;152(15–16):364–372. doi: 10.1046/j.1563-258x.2002.02055.x.
  • Ibrahim NA, Shalaby AS, Farag RS, et al. Gynecological efficacy and chemical investigation of Vitex agnus-castus L. fruits growing in Egypt. Nat Prod Res. 2008;22(6):537–546. doi: 10.1080/14786410701592612.
  • Van Die MD, Burger HG, Teede HJ, et al. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med. 2013;79(7):562–575.
  • Dante G, Facchinetti F. Herbal treatments for alleviating premenstrual symptoms: a systematic review. J Psychosom Obstet Gynaecol. 2011;32(1):42–51. doi: 10.3109/0167482X.2010.538102.
  • Ambrosini A, Di Lorenzo C, Coppola G, et al. Use of Vitex agnus-castus in migrainous women with premenstrual syndrome: an open-label clinical observation. Acta Neurol Belg. 2013;113(1):25–29. doi: 10.1007/s13760-012-0111-4.
  • Zava DT, Dollbaum CM, Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med. 1998;217(3):369–378. doi: 10.3181/00379727-217-44247.
  • Kumar S, Sharma A. Anti-anxiety activity studies of various extracts of Turnera aphrodisiaca ward. J Herb Pharmacother. 2005;5(4):13–21. doi: 10.1080/J157v05n04_02.
  • Grandi G, Caroli M, Cortesi L, et al. Postmenopausal hormone therapy in BRCA gene mutation carriers: to whom and which? Expert Opin Drug Saf. 2020;19(8):1025–1030. doi: 10.1080/14740338.2020.1791818.
  • Varol U, Kucukzeybek Y, Alacacioglu A, et al. BRCA genes: BRCA 1 and BRCA 2. J Buon. 2018;23(4):862–866.
  • Ferraris C, Ballestra B, Listorti C, et al. Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen. Breast Cancer Res Treat. 2020;180(1):157–165. doi: 10.1007/s10549-020-05534-4.
  • Munro MG, Critchley HOD, Fraser IS, FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393–408. doi: 10.1002/ijgo.12666.
  • American College of Obstetricians and Gynecologists (ACOG). Premenstrual Syndrome (PMS). 2021.
  • Bradley L, Gueye N. The medical management of abnormal uterine bleeding in reproductive-aged women. Am J Obstet Gynecol. 2016;214(1):31e44–31e44. doi: 10.1016/j.ajog.2015.07.044.
  • Salazar EL, Calzada L. The role of progesterone in endometrial estradiol- and progesterone-receptor synthesis in women with menstrual disorders and habitual abortion. Gynecol Endocrinol. 2007;23(4):222–225. doi: 10.1080/09513590701254030.
  • Jewson M, Purohit P, Lumsden MA. Progesterone and abnormal uterine bleeding/menstrual disorders. Best Pract Res Clin Obstet Gynaecol. 2020;69:62–73. doi: 10.1016/j.bpobgyn.2020.05.004.
  • Iwata M, Oikawa Y, Shimizu Y, et al. Efficacy of low-dose estrogen-progestins and progestins in Japanese women with dysmenorrhea: a systematic review and network meta-analysis. Adv Ther. 2022;39(11):4892–4909. doi: 10.1007/s12325-022-02298-9.
  • Lundin C, Gemzell Danielsson K, Bixo M, et al. Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle—a double-blind, placebo-controlled randomized trial. Psychoneuroendocrinology. 2017;76:135–143. doi: 10.1016/j.psyneuen.2016.11.033.
  • Warhurst S, Rofe CJ, Brew BJ, et al. Effectiveness of the progestin-only pill for migraine treatment in women: a systematic review and meta-analysis. Cephalalgia. 2018;38(4):754–764. doi: 10.1177/0333102417710636.
  • Baker LJ, O’Brien PM. Premenstrual syndrome (PMS): a peri-menopausal perspective. Maturitas. 2012;72(2):121–125. doi: 10.1016/j.maturitas.2012.03.007.
  • Girman A, Lee R, Kligler B. An integrative medicine approach to premenstrual syndrome. Am J Obstet Gynecol. 2003;188(5 Suppl):S56–S65. doi: 10.1067/mob.2003.403.